US Patent 7101971 Erythropoietin analog-human serum albumin fusion
Patent 7101971 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on September, 2006 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7101971 Erythropoietin analog-human serum albumin fusion
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.